Company intelligence / Profile preview

Owl Rock Capital Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Owl Rock Capital Partners, now part of Blue Owl Capital, is an asset management firm specializing in private credit, with a significant life sciences division. They invest in biopharma companies through credit, royalties, and equity, and manage over $295B in assets. Key activities include direct lending and healthcare finance, with a portfolio that includes healthcare providers and biotech firms like ADC Therapeutics.

Industry: Investors

Partnerships

ADC TherapeuticsCowen Healthcare Investments (acquired funds)Oaktree

Beyond the preview

Go deeper on Owl Rock Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Owl Rock Capital Partners.

Explore the full profile